GlassScriptPhysician profile
Narendra K Gowda
NPI 1740232214
$1,424.84
in general payments reported to CMS, 2019-2025
15 companies · $317 in 2025
The $317 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $188 · 2021: $141 · 2022: $161 · 2023: $115 · 2024: $333 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $765.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $764.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $338.66 | 2020-2025 | Ozempic, Rybelsus |
| Pfizer INC. | $232.90 | 2019-2021 | |
| Opko Pharmaceuticals, LLC | $196.20 | 2022-2025 | Rayaldee |
| Astrazeneca Pharmaceuticals LP | $150.38 | 2021-2024 | Farxiga, Breztri |
| Medtronic, INC. | $110.50 | 2024 | Hawkone |
| Medtronic USA, INC. | $107.45 | 2019 | |
| Calliditas Therapeutics US INC. | $88.15 | 2022-2023 | Tarpeyo |
| Lilly USA, LLC | $66.37 | 2021-2024 | |
| Grt US Holding, INC. | $28.22 | 2022 | |
| Vifor Pharma, INC. | $24.39 | 2025 | Veltassa |
| Abbvie INC. | $22.83 | 2022 | |
| Exact Sciences Corporation | $15.40 | 2023 | Cologuard Collection Kit |
| Abbott Laboratories | $14.86 | 2022 | |
| Amgen INC. | $14.54 | 2024 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.99 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Narendra Gowda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.